Ocean Biomedical, Inc. Profile Avatar - Palmy Investing

Ocean Biomedical, Inc.

Ocean Biomedical, Inc., a biopharmaceutical company, focuses on discovering and developing therapeutic products in oncology, fibrosis, infectious diseases, and inflammation. The company is developing mono-specific and bi-specific humanized monoclonal ant…

Biotechnology
US, Providence [HQ]
US · Macroeconomic Factors/Risks · Forecasts

Macro

Ocean Biomedical, Inc. mainly operates in US (Alpha-2: US, Alpha-3: USA)

United States
Analysis Results
B Overall Rating
19 Analyzed Indicators
B Annual Indicators Rating
16 Analyzed Indicators
B+ Monthly Indicators Rating
3 Analyzed Indicators
Breakdown

All indicators comes from high quality sources, such as the world bank, OECD, FRED and manuel datasets such as Premiums by Prof. Damodaran.

End of OCEA's Analysis
CIK: 1836612 CUSIP: 67644P105 ISIN: US67644C1045 LEI: - UEI: -
Secondary Listings
OCEA has no secondary listings inside our databases.